Nov 13 (Reuters) - Resmed Inc (RMD)
- Refers to United Kingdom case with Fisher & Paykel
- Ruling has no impact on Resmed's commercial operations in UK
- Ruling is limited only to UK and has no impact on Resmed's pending cases against Fisher & Paykel in United States, New Zealand or Germany
News: RMD Resmed updates on United Kingdom case with Fisher & Paykel
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
